Cargando…

Development and validation of the Patient Opioid Education Measure

BACKGROUND: Although there are screening tools to aid clinicians in assessing the risk of opioid misuse, an instrument to assess opioid-related knowledge is not currently available. The purpose of this study was to develop a content-valid, understandable, readable, and reliable Patient Opioid Educat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Lorraine S, Wexler, Randell K, Miser, W Frederick, McDougle, Leon, Haddox, J David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775672/
https://www.ncbi.nlm.nih.gov/pubmed/24049456
http://dx.doi.org/10.2147/JPR.S50715
_version_ 1782477402995163136
author Wallace, Lorraine S
Wexler, Randell K
Miser, W Frederick
McDougle, Leon
Haddox, J David
author_facet Wallace, Lorraine S
Wexler, Randell K
Miser, W Frederick
McDougle, Leon
Haddox, J David
author_sort Wallace, Lorraine S
collection PubMed
description BACKGROUND: Although there are screening tools to aid clinicians in assessing the risk of opioid misuse, an instrument to assess opioid-related knowledge is not currently available. The purpose of this study was to develop a content-valid, understandable, readable, and reliable Patient Opioid Education Measure (POEM). METHODS: Using concept mapping, clinicians caring for patients with chronic pain participated in brainstorming, sorting, and rating need-to-know information for patients prescribed opioids. Concept mapping analyses identified seven clusters addressing knowledge and expectations associated with opioid use, including medicolegal issues, prescribing policies, safe use and handling, expected outcomes, side effects, pharmacology, and warnings. RESULTS: The 49-item POEM was verbally administered to 83 patients (average age 51.3 ± 9.8 years, 77.1% female, 47.1% African American) taking opioids for chronic nonmalignant pain. Patients averaged in total 63.9% ± 14.3% (range 23%–91%) correct responses on the POEM. The POEM demonstrated substantial test-retest reliability (interclass correlation coefficient 0.87). The POEM had a mean readability Lexile (L) score of 805.9 ± 257.3 L (equivalent to approximately a US fifth grade reading level), with individual items ranging from 280 L to 1370 L. CONCLUSION: The POEM shows promise for rapidly identifying patients’ opioid-related knowledge gaps and expectations. Correcting misunderstandings and gaps could result in safer use of opioids in a clinical care setting.
format Online
Article
Text
id pubmed-3775672
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37756722013-09-18 Development and validation of the Patient Opioid Education Measure Wallace, Lorraine S Wexler, Randell K Miser, W Frederick McDougle, Leon Haddox, J David J Pain Res Original Research BACKGROUND: Although there are screening tools to aid clinicians in assessing the risk of opioid misuse, an instrument to assess opioid-related knowledge is not currently available. The purpose of this study was to develop a content-valid, understandable, readable, and reliable Patient Opioid Education Measure (POEM). METHODS: Using concept mapping, clinicians caring for patients with chronic pain participated in brainstorming, sorting, and rating need-to-know information for patients prescribed opioids. Concept mapping analyses identified seven clusters addressing knowledge and expectations associated with opioid use, including medicolegal issues, prescribing policies, safe use and handling, expected outcomes, side effects, pharmacology, and warnings. RESULTS: The 49-item POEM was verbally administered to 83 patients (average age 51.3 ± 9.8 years, 77.1% female, 47.1% African American) taking opioids for chronic nonmalignant pain. Patients averaged in total 63.9% ± 14.3% (range 23%–91%) correct responses on the POEM. The POEM demonstrated substantial test-retest reliability (interclass correlation coefficient 0.87). The POEM had a mean readability Lexile (L) score of 805.9 ± 257.3 L (equivalent to approximately a US fifth grade reading level), with individual items ranging from 280 L to 1370 L. CONCLUSION: The POEM shows promise for rapidly identifying patients’ opioid-related knowledge gaps and expectations. Correcting misunderstandings and gaps could result in safer use of opioids in a clinical care setting. Dove Medical Press 2013-09-05 /pmc/articles/PMC3775672/ /pubmed/24049456 http://dx.doi.org/10.2147/JPR.S50715 Text en © 2013 Wallace et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Original Research
Wallace, Lorraine S
Wexler, Randell K
Miser, W Frederick
McDougle, Leon
Haddox, J David
Development and validation of the Patient Opioid Education Measure
title Development and validation of the Patient Opioid Education Measure
title_full Development and validation of the Patient Opioid Education Measure
title_fullStr Development and validation of the Patient Opioid Education Measure
title_full_unstemmed Development and validation of the Patient Opioid Education Measure
title_short Development and validation of the Patient Opioid Education Measure
title_sort development and validation of the patient opioid education measure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775672/
https://www.ncbi.nlm.nih.gov/pubmed/24049456
http://dx.doi.org/10.2147/JPR.S50715
work_keys_str_mv AT wallacelorraines developmentandvalidationofthepatientopioideducationmeasure
AT wexlerrandellk developmentandvalidationofthepatientopioideducationmeasure
AT miserwfrederick developmentandvalidationofthepatientopioideducationmeasure
AT mcdougleleon developmentandvalidationofthepatientopioideducationmeasure
AT haddoxjdavid developmentandvalidationofthepatientopioideducationmeasure